ADAPTIMMUNE THERAPEUTICS PLC's ticker is ADAP and the CUSIP is 00653A107. A total of 45 filers reported holding ADAPTIMMUNE THERAPEUTICS PLC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $8,624,000 | -54.3% | 2,024,400 | -43.0% | 0.15% | -54.0% |
Q1 2021 | $18,851,000 | -1.5% | 3,550,000 | 0.0% | 0.33% | -1.2% |
Q4 2020 | $19,135,000 | -78.2% | 3,550,000 | -67.7% | 0.33% | -73.5% |
Q3 2020 | $87,780,000 | -12.4% | 11,000,000 | +7.8% | 1.25% | -37.0% |
Q2 2020 | $100,170,000 | +2871.5% | 10,200,000 | +5446.5% | 1.98% | +113.4% |
Q2 2015 | $3,371,000 | – | 183,900 | – | 0.93% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
NEA Management Company, LLC | 12,025,999 | $66,263,000 | 2.30% |
Abingworth LLP | 250,000 | $1,375,000 | 1.02% |
Tekla Capital Management LLC | 1,466,368 | $8,080,000 | 0.31% |
Rock Springs Capital Management LP | 875,000 | $4,821,000 | 0.28% |
QVT Financial LP | 1,360,647 | $6,940,000 | 0.22% |
Vident Investment Advisory, LLC | 232,641 | $1,282,000 | 0.13% |
Hillhouse Capital Management | 1,190,476 | $6,560,000 | 0.13% |
Orbimed Advisors | 1,914,660 | $10,550,000 | 0.12% |
Granite Investment Partners, LLC | 195,571 | $1,078,000 | 0.07% |
Monashee Investment Management LLC | 25,000 | $138,000 | 0.06% |